AEON Biopharma

AEONNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$12.097 M

$0.24 -1.54%

Close of 18 Sept 2026

Revenue

—

Not reported

Earnings

-$39.2M

Loss-making

Shares outstanding

49,882,790

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#419Adial PharmaceuticalsADIL$12.8M
#420Kiora PharmaceuticalsKPRX$12.2M
#421AEON BiopharmaAEON$12.1M
#422BioLineRxBLRX$12.1M
#423NeuroSense TherapeuticsNRSN$12.0M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of AEON Biopharma, worth $243.5K. Grants and option exercises are excluded.

Timothy P. Lynch$243.5K
1,150,000 shares at $0.21 on 19 Aug 2026 · filed 21 Aug 2026

What if AEON Biopharma were worth as much as…

Open the what-if tool →

Gold $30.4T

$609,177.19

Per share 2,512,071× higher

Bitcoin $1.64T

$32,797.44

Per share 135,247× higher

Nvidia $5.36T

$107,385.87

Per share 442,828× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for AEON Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.